Psoriatic Arthritis

Top Story

IAS 2018: Advances, collaboration in immune-mediated inflammatory diseases

IAS 2018: Advances, collaboration in immune-mediated inflammatory diseases
April 26, 2018
In the Journals

Cimzia safe during pregnancy

April 16, 2018
Certolizumab pegol for chronic inflammatory disease does not pose a teratogenic risk for pregnant women, nor does it increase the risk for fetal death, according to…
In the Journals

Subcutaneous Cosentyx effective against PsA at week 24

April 10, 2018
Subcutaneous secukinumab in doses of 300 mg and 150 mg significantly improved symptoms of psoriatic arthritis, and slowed the disease’s radiographic progression at…
In the JournalsPerspective

Women with RA, psoriasis at increased CV risk

April 9, 2018
Recently published findings revealed that women with rheumatoid arthritis and psoriasis have an increased risk for major adverse cardiac events compared with the general…
More Headlines »
CME ABIM MOC

Ace the Case: A 29-year-old Woman with Psoriasis Vulgaris

There is no commercial support for this activity.

This “Ace the Case” study will discuss the assessment and treatment of a 29-year-old woman with Psoriasis Vulgaris…
More »
Video
Meeting News

VIDEO: Orencia showed long-term safety, efficacy

January 11, 2017
More »
Resource Centers
Interdisciplinary Autoimmune Summit

Interdisciplinary Autoimmune Summit

CME ABIM MOC

Ace the Case: A 56-year-old Caucasian Female with a 5-year History of Seropositive Rheumatoid Arthritis

There is no commercial support for this activity.

This “Ace the Case” study will discuss treatment options in patients with rheumatoid arthritis who have had an…
More »